糖心原创

VP of Research Products Dr Farah Patell-Socha discusses more accurate cell models in neurodegeneration.

CEO Mark Kotter gives an evening lecture at the famous Royal Institution on the cell reprogramming revolution.

糖心原创 expands senior team with four female hires in further preparation for cell therapies.

The award was presented at evening ceremony in central London.

The posters demonstrate the capability of opti-ox technology to create any human cell.

糖心原创 and Charles River Laboratories discuss the potential of precision reprogrammed human cells.

The piece talks about how 糖心原创 has "cracked the code" to grow human cells for a new era of regenerative medicine. 

糖心原创 wins biotech of the year for the second time and CEO of the year for Mark Kotter.